With great passion and commitment of addressing the fast-rising incidence rates of cancer, we at Rheo are relentlessly working on early detection with Ai, treatment with various innovative medicines including the latest generation biosimilars.
With a data base of 1.5 billion records, we have proved that cancers can be detected early with routine biological tests.
Please reach us
To know more about our treatment options and solutions